|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
Back to Reuters Health News Archives
Reuters Health News: 04-10-2006
CHICAGO (Reuters) - Yoga, the ancient practice of postures, breathing and meditation, is gaining a lot of attention from the material world that its serious practitioners are trying to escape.
NEW YORK (Reuters Health) - Although weight loss is a cornerstone of managing diabetes, many people who have the disease don't know what their ideal weight range should be, a study suggests.
WASHINGTON (Reuters) - U.S. regulators are reviewing a small study that reported high levels of platinum in the hair, breast milk and other samples from women who had silicone gel-filled breast implants, officials said on Friday.
TOKYO (Reuters) - Tamako Kondo says 10 minutes of exercise every morning keeps her fit.
CHICAGO (Reuters) - Care of the terminally ill, once solely the domain of nonprofit organizations, is becoming a big business.
NEW YORK (Reuters Health) - High-dose intravenously administered vitamin C apparently led to longer-than-expected survival in three patients with advanced cancer, doctors at the National Institutes of Health in Bethesda, Maryland and colleagues in Canada report. Two of the three patients are still alive without evidence of disease.
NEW YORK (Reuters Health) - The medical and environmental risks often associated with premature birth affect the attention abilities of premature children all the way throughout adolescence, researchers report in the journal Child Development.
WASHINGTON (Reuters) - U.S. prices for brand name prescription medications used most by older patients rose an average 6 percent in 2005, outpacing inflation for the sixth year in a row, according to a report released on Monday.
BEIJING (Reuters) - A senior Chinese health official has vowed harsh punishment for people profiting from surrogate motherhood, a practice banned years ago along with the sale of eggs and sperm, state media said on Monday.
ZURICH (Reuters) - Novartis has filed for approval from regulators to market its once-a-day cancer pill Glivec for a rare form of skin cancer as well as three kinds of blood disorders, all thought to share the same root.
|
|